ArticleDiagnostics (Basel, Switzerland)2026
Safe Prostatic Artery Embolization with Cyanoacrylate: Representative Cases Demonstrating Non-Target Artery Preservation.
Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study describes five case of prostatic artery embolization (PAE) using n-butyl cyanoacrylate methylsulfone (NBCA; Glubran 2, GEM; Viareggio, Italy) to evaluate its technical advantages, against standard particulate embolization, in managing complex pelvic vascular anatomy while preserving non-target arteries, with particular focus on penile artery protection. NBCA was mixed with iodized oil (Lipiodol Ultra Fluid; Guerbet, Aulnay-sous-Bois, France) at 1:5 dilution and injected in small aliquots (0.1-0.3 mL) under fluoroscopy using a blocked-flow technique, with injection stopped at reflux into the horizontal PA segment. After a few seconds, before the complete polymerization of the glue, the microcatheter is quickly withdrawn, flushed, and reused for the contralateral side. NBCA allowed precise embolic control through distinct mechanisms (direct distal, indirect distal, proximal, reflux and controlateral control), avoiding the need for protective coiling. Glue-based PAE seems a reproducible, safe, and efficient alternative to particulate embolization, offering enhanced embolization control and non-target artery preservation in anatomically complex patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.